These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30191652)
1. Use of acetazolamide in the treatment of patients with refractory congestive heart failure. Núñez J; Heredia R; Payá A; Sanchis I; Del Prado S; Miñana G; Santas E; de la Espriella R; Núñez E; Sanchis J; Bayés-Genís A Cardiovasc Ther; 2018 Dec; 36(6):e12465. PubMed ID: 30191652 [TBL] [Abstract][Full Text] [Related]
2. Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study. Imiela T; Budaj A Clin Drug Investig; 2017 Dec; 37(12):1175-1181. PubMed ID: 28965280 [TBL] [Abstract][Full Text] [Related]
3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
4. Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the 'chloride theory' for heart failure pathophysiology. Kataoka H Heart Vessels; 2019 Dec; 34(12):1952-1960. PubMed ID: 31114959 [TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [TBL] [Abstract][Full Text] [Related]
6. Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factors. Kunin M; Arad M; Dinour D; Freimark D; Holtzman EJ Blood Purif; 2013; 35(4):285-94. PubMed ID: 23712042 [TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574 [TBL] [Abstract][Full Text] [Related]
8. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Gotloib L; Fudin R; Yakubovich M; Vienken J Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii32-6. PubMed ID: 16024831 [TBL] [Abstract][Full Text] [Related]
9. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184 [TBL] [Abstract][Full Text] [Related]
10. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190 [TBL] [Abstract][Full Text] [Related]
15. Bioelectrical impedance analysis as an assessment of diuresis in congestive heart failure. Coodley EL; Segal JL; Smith DH; Neutel JM Ann Pharmacother; 1995 Nov; 29(11):1091-5. PubMed ID: 8573950 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. Rosenberg J; Gustafsson F; Galatius S; Hildebrandt PR Cardiovasc Drugs Ther; 2005 Aug; 19(4):301-6. PubMed ID: 16189620 [TBL] [Abstract][Full Text] [Related]
17. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP; JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440 [TBL] [Abstract][Full Text] [Related]
18. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467 [TBL] [Abstract][Full Text] [Related]
19. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399 [TBL] [Abstract][Full Text] [Related]
20. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center. De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]